- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/404 - Indoles, e.g. pindolol
Patent holdings for IPC class A61K 31/404
Total number of patents in this class: 5282
10-year publication summary
|
351
|
370
|
391
|
377
|
356
|
372
|
379
|
396
|
377
|
228
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1595 |
97 |
| Novartis AG | 10850 |
75 |
| The Regents of the University of California | 19929 |
50 |
| Boehringer Ingelheim International GmbH | 4648 |
49 |
| The Johns Hopkins University | 5669 |
46 |
| Janssen Pharmaceuticals, Inc. | 427 |
35 |
| F. Hoffmann-La Roche AG | 7921 |
33 |
| Centre National de La Recherche Scientifique | 10432 |
31 |
| Arena Pharmaceuticals, Inc. | 366 |
31 |
| Pfizer Inc. | 3381 |
29 |
| Allergan, Inc. | 2346 |
28 |
| Katholieke Universiteit Leuven | 1190 |
27 |
| Achillion Pharmaceuticals, Inc. | 164 |
26 |
| Emory University | 1629 |
26 |
| Bristol-myers Squibb Company | 4893 |
25 |
| Generics [UK] Limited | 118 |
25 |
| The Regents of the University of Michigan | 4697 |
24 |
| Merck Sharp & Dohme LLC | 3741 |
23 |
| Takeda Pharmaceutical Company Limited | 2709 |
22 |
| Astellas Pharma Inc. | 1092 |
22 |
| Other owners | 4558 |